Literature DB >> 22198586

An update on the management of traumatic brain injury.

S Honeybul1.   

Abstract

The management of traumatic brain injury (TBI) continues to evolve in a number of key areas. In the first instance there have been major advances in clinical information gathering and interpretation such that there are mow sophisticated prognostic models readily available. Secondly, technological advances have allowed the introduction of advanced multimodal monitoring which can provide real time information regarding the complex physiological and biochemical derangements that occur following TBI. Finally recent clinical trials have raised important questions regarding the efficacy or otherwise of important therapeutic options most notably hypothermia and decompressive craniectomy. The aim of this update is to highlight some of the areas where there has been advancement and controversy.

Entities:  

Mesh:

Year:  2011        PMID: 22198586

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  3 in total

1.  Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Jonathan Miller; Barry J Hoffer; Nigel H Greig; Chaim G Pick
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

2.  Toward an international initiative for traumatic brain injury research.

Authors:  Patrizia Tosetti; Ramona R Hicks; Elizabeth Theriault; Anthony Phillips; Walter Koroshetz; Ruxandra Draghia-Akli
Journal:  J Neurotrauma       Date:  2013-07-11       Impact factor: 5.269

3.  Erythropoietin Attenuates the Brain Edema Response after Experimental Traumatic Brain Injury.

Authors:  Jonas Blixt; Eli Gunnarson; Michael Wanecek
Journal:  J Neurotrauma       Date:  2018-01-11       Impact factor: 5.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.